Doctor profile · Federal record
Dr. NEIL IYENGAR, M.D.
Hematology & Oncology Physician (CMS: MEDICAL ONCOLOGY) · Internal Medicine Physician · Medical Oncology Physician · NEW YORK, NY
- NPI 1194987230
- Accepts Medicare
- MIPS 84.6 / 100 · 2023
- 18 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1275 YORK AVE
NEW YORK, NY 100656007
(212) 639-2000
Credentials & registration
- NPI registered
- June 2008 — 18 yrs on file
- Profile last updated
- August 7, 2014
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (3)
- New York #260648-1 · Illinois #125054742 · New York #260648
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1194987230. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
141
Distinct HCPCS
3
Medicare allowed
$17,857
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 106 | 62 | $109 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 20 | 14 | $160 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 15 | 15 | $204 |
In context: peer comparison
Among 103 peers in this city , average services per provider: 411. This provider delivers 0.3× the peer median.Open Payments
Industry payments received
All-time total
$135,954
Transactions
91
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 15 | $37,915.42 | |
| Gilead Sciences, Inc. | 24 | $23,072.23 | |
| Genentech USA, Inc. | 19 | $22,362.51 | |
| AstraZeneca Pharmaceuticals LP | 14 | $21,481.92 | |
| Daiichi Sankyo Company LTD | 5 | $14,465.81 | |
| Novartis Pharmaceuticals Corporation | 7 | $8,693.44 | |
| Davol Inc. | 2 | $2,400.00 | |
| Stemline Therapeutics Inc. | 1 | $1,950.00 | |
| AstraZeneca UK Limited | 3 | $1,899.97 | |
| Daiichi Sankyo Inc. | 1 | $1,712.50 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
92
Patients
21
Total drug cost
$2,212
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 60 | 21 | $1,190 |
| Anastrozole | Generic | 17 | 0 | $558 |
| Tamoxifen Citrate | Generic | 15 | 0 | $464 |